David S. Tierney - 08 Apr 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Issuer symbol
CPRX
Transactions as of
08 Apr 2024
Net transactions value
-$291,750
Form type
4
Filing time
10 Apr 2024, 17:15:34 UTC
Previous filing
16 Feb 2024
Next filing
23 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $100,250 +25,000 +7.2% $4.01 373,874 08 Apr 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $392,000 -25,000 -6.7% $15.68 348,874 08 Apr 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +25,000 +14% $0.000000 203,931 08 Apr 2024 Common Stock 25,000 $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.55 to $15.77 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.